A novel mechanism of Ha-ras oncogene action: regulation of fibronectin mRNA levels by a nuclear posttranscriptional event.
Open Access
- 1 May 1994
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 14 (5) , 3085-3093
- https://doi.org/10.1128/mcb.14.5.3085
Abstract
Although loss of cell surface fibronectin (FN) is a hallmark of many oncogenically transformed cells, the mechanisms responsible for this phenomenon remain poorly understood. The present study utilized the nontumorigenic human osteosarcoma cell line TE-85 to investigate the effects of induced Ha-ras oncogene expression on FN biosynthesis. TE-85 cells were stably transfected with metallothionein-Ha-ras fusion genes, and the effects of metal-induced ras expression on FN biosynthesis were determined. Induction of the ras oncogene, but not proto-oncogene, was accompanied by a decrease in total FN mRNA and protein levels. Transfection experiments indicated that these oncogene effects were not due to reduced FN promoter activity, suggesting that a posttranscriptional mechanism was involved. The most common mechanism of posttranscriptional regulation affects cytoplasmic mRNA stability. However, in this study the down-regulation of FN was identified as a nuclear event. A component of the ras effect was due to a mechanism affecting accumulation of processed nuclear FN RNA. Mechanisms that would generate such an effect include altered RNA processing and altered stability of the processed message in the nucleus. There was no effect of ras on FN mRNA poly(A) tail length or site of polyadenylation. There was also no evidence for altered splicing at the ED-B domain of FN mRNA. This demonstration of nuclear posttranscriptional down-regulation of FN by the Ha-ras oncogene identifies a new level at which ras oncoproteins can regulate gene expression and thus contribute to development of the malignant phenotype.Keywords
This publication has 41 references indexed in Scilit:
- Modulation of Activity of the Promoter of the Human MDR 1 Gene by Ras and p53Science, 1992
- The p53 tumour suppressor geneNature, 1991
- Generation of full-length cDNA recombinant vectors for the transient expression of human fibronectin in mammalian cell linesExperimental Cell Research, 1991
- ALTERNATIVE SPLICING IN THE CONTROL OF GENE EXPRESSIONAnnual Review of Genetics, 1989
- A simple phase-extraction assay for chloramphenicol acyltransferase activityGene, 1988
- Dose effects of transfected c-Ha-rasVal 12 oncogene in transformed cell clonesExperimental Cell Research, 1987
- Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologueNature, 1983
- T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genesNature, 1982
- Transfer of purified herpes virus thymidine kinase gene to cultured mouse cellsCell, 1977
- Cultivation in vitro of cells derived from a human osteosarcomaCancer, 1971